New York, USA – June 25, 2020 – Acroscell, the division of Creative Bioarray, focusing on offering high quality biotechnology services and products including cardiac & neuronal safety profiling and translational assays for the academia, pharmaceutical, and biotechnology industries. Recently it announced the release of ionic screening services with primary screening and functional profiling assays to help discover potential compounds targeting ion channels.
Acrocell provides a wide range of ion channel assays that can quickly and accurately provide results for drug discovery and development research worldwide. The in-house experts offer ion channel screening services on various high-quality electrophysiological platforms. These services include:
• Compound screening
The screening compound system allows chemists and compound managers to quickly and easily purchase screening compounds for HTS library.
• Cell line optimization
Acrocell scientists have extensive experience in developing, optimizing and validating stable cell lines expressing recombinant and endogenous ion channels.
• Analysis and development
Acrocell scientists have more than ten years of practical experience in constructing and optimizing automated and manual patch clamp analysis for various ion channel targets. From medium-throughput SAR or hit discovery to specialized biophysical and mechanism-of-action studies of hit series or lead compounds, our scientists are able to fully customize ion channel assays at different stages of the screening cascade.
• Ion channel Screening library
Acroscell has developed a comprehensively validated screening and characterization method, as well as a stable channel expression cell line library for high-throughput screening, potential customer optimization studies, and selective characterization. All the tests have been validated by experienced electrophysiologists through strictly optimized rules to ensure the highest quality and consistent data.
Acrocell team provides the following services:
• Target assessment-drug targets
• HITs identification
• Lead optimization
• Nomination of clinical candidates
• Computer-aided drug design
• SAR research
With extensive experience in the field of medicinal chemistry, Acrocell can efficiently and cost-effectively advance the drug discovery program to the stage of development and clinical trials.
The Advantage of Ionic Screening Service offered by Acrocell
• Advanced gold standard manual patch clamp technology
• A variety of automated platform detection can meet different needs
• Reliable and short turnaround time
“As an experienced electrophysiology experiment expert, Acroscell provides the main screening and functional analysis methods to help discover potential compounds targeting ion channels. We provide you with an in-depth understanding of the relationship and interaction between compounds and ion channel targets,” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “Based on timely communication and timely reports, Acroscell is committed to working closely with your team to accelerate your project at the most competitive price.”
As a mature division of Creative Bioarray, Acroscell definitely will be the ideal and reliable innovation partner in research endeavors. With the support of professional scientists and years of experience, We are capable to provide a knowledgeable, collaborative and flexible service to our clients so as to accelerated drug development and improved research quality for worldwide projects.